← Back to Search

Dental Appliance

Dental Appliance for Sleep Apnea in Children

Phase 4
Recruiting
Led By Mark Musso, DDS
Research Sponsored by Vivos BioTechnologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Over the age of 6 and under the age of 18 years
Permanent dentition or mixed dentition at time of evaluation
Must not have
Severe obstructive sleep apnea (AHI> 10/hr)
Enlarged tonsils of a Grade 4 (>75% of space between pillars)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up an initial evaluation before treatment and upon completion of the study (an average of 1 year)
Awards & highlights
No Placebo-Only Group
Pivotal Trial
Drug Has Already Been Approved

Summary

This trial tests if a mouthguard can reduce sleep-disordered breathing in kids.

Who is the study for?
This trial is for children aged 6-18 in the U.S. with sleep-disordered breathing symptoms like snoring or mild to moderate obstructive sleep apnea, who are also getting orthodontic treatment. They must have good oral hygiene and not have severe respiratory conditions, uncontrolled diabetes, braces already on, very large tonsils, or TMJ issues.
What is being tested?
The study is testing if a marketed mouthguard (Vivos Grow/Vivos Way Device) can help reduce symptoms of sleep-disordered breathing in children when used alongside their orthodontic treatment.
What are the potential side effects?
Potential side effects may include discomfort from wearing the device, changes in bite alignment over time, soreness in teeth or jaws, and possible irritation inside the mouth.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 6 and 18 years old.
Select...
I have all permanent teeth or a mix of permanent and baby teeth.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe sleep apnea with more than 10 interruptions per hour.
Select...
My tonsils are very large, taking up most of the space in my throat.
Select...
I do not have severe asthma, emphysema, COPD, or similar breathing problems.
Select...
My diabetes is not under control.
Select...
I have poor dental health.
Select...
I have been diagnosed with a TMJ condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~an initial evaluation before treatment and upon completion of the study (an average of 1 year)
This trial's timeline: 3 weeks for screening, Varies for treatment, and an initial evaluation before treatment and upon completion of the study (an average of 1 year) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pediatric Sleep Questionnaire
Sleep Study
Secondary study objectives
Airway Volume
Sleep Related Breathing Disordered Questionnaire (SRBD)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention Arm will use Vivos Grow/Vivos Way DeviceExperimental Treatment1 Intervention
This intervention will compare measurements prior to treatment with measurements post-treatment.

Find a Location

Who is running the clinical trial?

Vivos BioTechnologies, Inc.Lead Sponsor
Mark Musso, DDSPrincipal InvestigatorMusso Family Dentistry

Media Library

Vivos Grow/Vivos Way Device (Dental Appliance) Clinical Trial Eligibility Overview. Trial Name: NCT05661747 — Phase 4
Sleep Apnea Research Study Groups: Intervention Arm will use Vivos Grow/Vivos Way Device
Sleep Apnea Clinical Trial 2023: Vivos Grow/Vivos Way Device Highlights & Side Effects. Trial Name: NCT05661747 — Phase 4
Vivos Grow/Vivos Way Device (Dental Appliance) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05661747 — Phase 4
~2 spots leftby Dec 2024